Fny Investment Advisers, LLC Aslan Pharmaceuticals LTD Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 10, 2020	SELL	$0.37 - $5.2 $7,067 - $99,320	-19,100 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$1.51 - $3.85 $10,559 - $26,923	6,993 Added 57.76%	19,100 $33,000
Q2 2019 Jul 24, 2019	SELL	$2.91 - $4.5 $43,053 - $66,577	-14,795 Reduced 55.0%	12,107 $37,000
Q1 2019 Apr 17, 2019	BUY	$3.1 - $4.8 $1,550 - $2,400	500 Added 1.89%	26,902 $111,000
Q4 2018 Jan 22, 2019	BUY	$2.86 - $8.0 $75,509 - $211,216	26,402 New	26,402 $104,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.